November 17, 2014 / 6:21 AM / 5 years ago

Roche says Avastin approved in U.S. for type of ovarian cancer

A general view shows the headquarter of Swiss drugmaker Roche in Basel July 21, 2008. REUTERS/Christian Hartmann

ZURICH (Reuters) - Roche said on Monday that the U.S. health regulator approved its Avastin drug as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy.

Avastin, which is already approved in Europe to treat advanced stages of breast cancer, colorectal cancer, non-small cell lung cancer, kidney cancer and ovarian cancer, was Roche’s biggest seller last year with sales of 6.25 billion Swiss francs (6.53 billion US dollar).

Reporting By Katharina Bart; Editing by Himani Sarkar

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below